Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Parkinson's Disease

  Free Subscription


1 BMC Neurol
1 Exp Neurol
2 J Biol Chem
1 J Neural Transm (Vienna)
1 Lancet Neurol
1 Mov Disord
2 Neurobiol Dis
1 Neurology
1 PLoS One
1 Science

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Neurol

  1. KRIEGER T, Jozwiak L, Ebersbach G, Suess T, et al
    Exploring the lived experiences of individuals with Parkinson's disease and their relatives: insights into care provision experiences, disease management support, self-management strategies, and future needs in Germany (qualitative study).
    BMC Neurol. 2024;24:208.
    PubMed         Abstract available

    Exp Neurol

  2. LEI J, Tang LL, Jing R, You HJ, et al
    Antinociceptive role of the thalamic dopamine D3 receptor in descending modulation of intramuscular formalin-induced muscle nociception in a rat model of Parkinson's disease.
    Exp Neurol. 2024 Jun 13:114846. doi: 10.1016/j.expneurol.2024.114846.
    PubMed         Abstract available

    J Biol Chem

  3. WATANABE A, Koyano F, Imai K, Hizukuri Y, et al
    The origin of esterase activity of Parkinson's disease causative factor DJ-1 implied by evolutionary trace analysis of its prokaryotic homolog HchA.
    J Biol Chem. 2024 Jun 13:107476. doi: 10.1016/j.jbc.2024.107476.
    PubMed         Abstract available

  4. DEDERER V, Sanz Murillo M, Karasmanis EP, Hatch KS, et al
    A designed ankyrin-repeat protein that targets Parkinson's disease-associated LRRK2.
    J Biol Chem. 2024 Jun 12:107469. doi: 10.1016/j.jbc.2024.107469.
    PubMed         Abstract available

    J Neural Transm (Vienna)

  5. LEWITT PA, Hong L, Moehle MS
    Anticholinergic drugs for parkinsonism and other movement disorders.
    J Neural Transm (Vienna). 2024 Jun 21. doi: 10.1007/s00702-024-02799.
    PubMed         Abstract available

    Lancet Neurol

  6. GOEDERT M, Griesinger C, Outeiro TF, Riek R, et al
    Abandon the NAC in alpha-synuclein.
    Lancet Neurol. 2024;23:669.

    Mov Disord

  7. WANG X, Fu S, Yoo K, Wang X, et al
    Individualized Structural Perturbations on Normative Brain Connectome Restrict Deep Brain Stimulation Outcomes in Parkinson's Disease.
    Mov Disord. 2024 Jun 18. doi: 10.1002/mds.29874.
    PubMed         Abstract available

    Neurobiol Dis

  8. TEZUKA T, Ishiguro M, Taniguchi D, Osogaguchi E, et al
    Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease.
    Neurobiol Dis. 2024 Jun 18:106571. doi: 10.1016/j.nbd.2024.106571.
    PubMed         Abstract available

  9. GAO AYL, Montagna DR, Hirst WD, Temkin PA, et al
    RIT2 regulates autophagy lysosomal pathway induction and protects against alpha-synuclein pathology in a cellular model of Parkinson's disease.
    Neurobiol Dis. 2024;199:106568.
    PubMed         Abstract available


  10. OH Y, Kim JS, Lyoo CH, Park G, et al
    Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease-Related Cognitive Impairment.
    Neurology. 2024;103:e209498.
    PubMed         Abstract available

    PLoS One

  11. CRIGHTON EJ, Ouedraogo AM, Sawada M, Mestre TA, et al
    Patterns and determinants of health care utilization among people with Parkinson's disease: A population-based analysis in Ontario, Canada.
    PLoS One. 2024;19:e0305062.
    PubMed         Abstract available


  12. HUANG Q, Chan KY, Wu J, Botticello-Romero NR, et al
    An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wide gene delivery.
    Science. 2024;384:1220-1227.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.